| Lastest Insider Transactions Of Kymera Therapeutics, Inc. ( KYMR ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Directior | 2025-12-10 | Sell | 236,588 | 91.72 | 21,699,044 | 2025-12-12 18:37:21 |
| KYMR | Kymera Therapeutics, Inc. | BAKER BROS. ADVISORS LP | Directior 10% Owner | 2025-12-11 | Buy | 2,005,813 | 86.00 | 172,499,920 | 2025-12-11 16:19:37 |
| KYMR | Kymera Therapeutics, Inc. | Albers Jeffrey W. | Directior | 2025-12-08 | Sell | 5,000 | 89.76 | 448,823 | 2025-12-08 18:09:43 |
| KYMR | Kymera Therapeutics, Inc. | Albers Jeffrey W. | Directior | 2025-12-08 | Option Exercise | 5,000 | 14.18 | 70,900 | 2025-12-08 18:09:43 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2025-12-08 | Sell | 100,000 | 89.17 | 8,917,000 | 2025-12-08 18:09:20 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2025-12-08 | Option Exercise | 100,000 | 2.08 | 208,000 | 2025-12-08 18:09:20 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2025-12-08 | Sell | 49,307 | 88.67 | 4,371,833 | 2025-12-08 18:09:11 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2025-12-08 | Option Exercise | 49,307 | 5.33 | 262,806 | 2025-12-08 18:09:11 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2025-10-29 | Sell | 30,000 | 60.99 | 1,829,737 | 2025-10-29 17:19:12 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2025-10-29 | Option Exercise | 30,000 | 2.08 | 62,400 | 2025-10-29 17:19:12 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2025-10-15 | Sell | 59,576 | 61.42 | 3,659,254 | 2025-10-15 17:28:20 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2025-10-15 | Option Exercise | 51,209 | 1.64 | 84,185 | 2025-10-15 17:28:20 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2025-10-13 | Sell | 3,114 | 60.00 | 186,840 | 2025-10-14 17:11:20 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2025-10-13 | Option Exercise | 1,473 | 1.66 | 2,448 | 2025-10-14 17:11:20 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2025-10-13 | Sell | 3,114 | 60.00 | 186,840 | 2025-10-14 17:11:20 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2025-10-13 | Option Exercise | 1,473 | 1.66 | 2,448 | 2025-10-14 17:11:20 |
| KYMR | Kymera Therapeutics, Inc. | Albers Jeffrey W. | Directior | 2025-10-13 | Sell | 5,000 | 59.19 | 295,949 | 2025-10-14 07:55:32 |
| KYMR | Kymera Therapeutics, Inc. | Albers Jeffrey W. | Directior | 2025-10-13 | Option Exercise | 5,000 | 10.34 | 51,700 | 2025-10-14 07:55:32 |
| KYMR | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | 2025-09-17 | Sell | 79,220 | 50.00 | 3,961,380 | 2025-09-17 17:16:16 |
| KYMR | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | 2025-09-17 | Option Exercise | 79,220 | 2.08 | 164,778 | 2025-09-17 17:16:16 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2025-09-16 | Sell | 30,000 | 49.00 | 1,470,000 | 2025-09-16 16:11:45 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2025-09-16 | Option Exercise | 30,000 | 2.08 | 62,400 | 2025-09-16 16:11:45 |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Directior | 2025-06-25 | Buy | 317,167 | 44.00 | 13,955,348 | 2025-07-01 18:41:37 |
| KYMR | Kymera Therapeutics, Inc. | BAKER BROS. ADVISORS LP | Directior | 2025-06-30 | Buy | 655,500 | 44.00 | 28,842,000 | 2025-06-30 20:15:05 |
| KYMR | Kymera Therapeutics, Inc. | Ridloff Elena | Directior | 2025-06-11 | Sell | 4,500 | 50.00 | 225,000 | 2025-06-11 16:47:50 |
| KYMR | Kymera Therapeutics, Inc. | Ridloff Elena | Directior | 2025-06-11 | Option Exercise | 4,500 | 20.29 | 91,305 | 2025-06-11 16:47:50 |
| KYMR | Kymera Therapeutics, Inc. | Esposito Pamela | Directior | 2025-06-03 | Sell | 5,000 | 49.04 | 245,186 | 2025-06-03 18:30:08 |
| KYMR | Kymera Therapeutics, Inc. | Esposito Pamela | Directior | 2025-06-03 | Option Exercise | 5,000 | 29.55 | 147,750 | 2025-06-03 18:30:08 |
| KYMR | Kymera Therapeutics, Inc. | Ridloff Elena | Directior | 2025-06-03 | Sell | 12,000 | 46.10 | 553,200 | 2025-06-03 18:30:07 |
| KYMR | Kymera Therapeutics, Inc. | Ridloff Elena | Directior | 2025-06-03 | Option Exercise | 12,000 | 27.67 | 332,040 | 2025-06-03 18:30:07 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2025-06-03 | Sell | 30,000 | 49.00 | 1,470,000 | 2025-06-03 18:30:05 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2025-06-03 | Option Exercise | 30,000 | 2.08 | 62,400 | 2025-06-03 18:30:05 |
| KYMR | Kymera Therapeutics, Inc. | Albers Jeffrey W. | Directior | 2025-06-03 | Sell | 6,349 | 49.00 | 311,101 | 2025-06-03 18:30:03 |
| KYMR | Kymera Therapeutics, Inc. | Albers Jeffrey W. | Directior | 2025-06-03 | Option Exercise | 6,349 | 10.34 | 65,649 | 2025-06-03 18:30:03 |
| KYMR | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | 2025-03-31 | Option Exercise | 25,000 | 2.08 | 52,000 | 2025-04-01 08:00:03 |
| KYMR | Kymera Therapeutics, Inc. | Chiniara Ellen | Chief Legal Officer | 2025-03-03 | Sell | 2,241 | 30.45 | 68,239 | 2025-03-03 18:30:08 |
| KYMR | Kymera Therapeutics, Inc. | Chadwick Jeremy G | Chief Operating Officer | 2025-03-03 | Sell | 1,383 | 30.45 | 42,113 | 2025-03-03 18:30:06 |
| KYMR | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | 2025-03-03 | Sell | 7,035 | 30.45 | 214,219 | 2025-03-03 18:30:05 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2025-03-03 | Sell | 5,740 | 30.45 | 174,786 | 2025-03-03 18:30:03 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2025-01-10 | Option Exercise | 10,000 | 2.08 | 20,800 | 2025-01-13 07:00:04 |
| KYMR | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | 2025-01-10 | Option Exercise | 10,000 | 2.08 | 20,800 | 2025-01-13 07:00:03 |
| KYMR | Kymera Therapeutics, Inc. | Esposito Pamela | Directior | 2024-12-02 | Sell | 2,500 | 49.00 | 122,500 | 2024-12-02 19:50:40 |
| KYMR | Kymera Therapeutics, Inc. | Esposito Pamela | Directior | 2024-12-02 | Option Exercise | 2,500 | 29.55 | 73,875 | 2024-12-02 19:50:40 |
| KYMR | Kymera Therapeutics, Inc. | Esposito Pamela | Directior | 2024-09-17 | Sell | 13,500 | 48.28 | 651,766 | 2024-09-17 18:20:32 |
| KYMR | Kymera Therapeutics, Inc. | Esposito Pamela | Directior | 2024-09-17 | Option Exercise | 13,500 | 23.86 | 322,075 | 2024-09-17 18:20:32 |
| KYMR | Kymera Therapeutics, Inc. | Albers Jeffrey W. | Directior | 2024-08-26 | Sell | 5,000 | 49.10 | 245,509 | 2024-08-26 18:31:05 |
| KYMR | Kymera Therapeutics, Inc. | Albers Jeffrey W. | Directior | 2024-08-26 | Option Exercise | 5,000 | 10.34 | 51,700 | 2024-08-26 18:31:05 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2024-07-15 | Sell | 39,600 | 45.53 | 1,803,143 | 2024-07-16 18:00:31 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2024-07-15 | Option Exercise | 39,600 | 2.08 | 82,368 | 2024-07-16 18:00:31 |
| KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Directior | 2024-07-09 | Sell | 453,960 | 38.21 | 17,346,918 | 2024-07-09 17:15:28 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2024-07-01 | Option Exercise | 18,773 | 5.33 | 100,060 | 2024-07-01 16:30:10 |
| KYMR | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | 2024-06-27 | Option Exercise | 25,000 | 2.08 | 52,000 | 2024-06-28 08:30:03 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2024-06-18 | Option Exercise | 14,413 | 2.08 | 29,979 | 2024-06-20 08:30:03 |
| KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Directior | 2024-06-12 | Sell | 26,940 | 35.27 | 950,174 | 2024-06-14 18:01:49 |
| KYMR | Kymera Therapeutics, Inc. | Horobin Joanna | Directior | 2024-06-07 | Sell | 8,500 | 32.99 | 280,400 | 2024-06-07 18:36:33 |
| KYMR | Kymera Therapeutics, Inc. | Horobin Joanna | Directior | 2024-06-07 | Option Exercise | 8,500 | 2.08 | 17,680 | 2024-06-07 18:36:33 |
| KYMR | Kymera Therapeutics, Inc. | Chadwick Jeremy G | Chief Operating Officer | 2024-05-23 | Sell | 2,575 | 34.99 | 90,105 | 2024-05-23 16:10:07 |
| KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Directior | 2024-03-14 | Sell | 127,543 | 40.25 | 5,133,263 | 2024-03-15 19:23:41 |
| KYMR | Kymera Therapeutics, Inc. | Atlas Venture Fund X, L.P. | 10% Owner | 2024-03-11 | Sell | 353,357 | 42.20 | 14,912,376 | 2024-03-13 19:53:50 |
| KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Directior | 2024-03-11 | Sell | 353,357 | 42.20 | 14,912,376 | 2024-03-13 19:52:35 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2024-03-01 | Sell | 3,344 | 41.86 | 139,967 | 2024-03-04 18:21:23 |
| KYMR | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | 2024-03-01 | Sell | 3,934 | 41.86 | 164,664 | 2024-03-04 18:12:04 |
| KYMR | Kymera Therapeutics, Inc. | Albers Jeffrey W. | Directior | 2024-02-20 | Sell | 5,000 | 39.05 | 195,258 | 2024-02-21 18:46:13 |
| KYMR | Kymera Therapeutics, Inc. | Albers Jeffrey W. | Directior | 2024-02-20 | Option Exercise | 5,000 | 10.34 | 51,700 | 2024-02-21 18:46:13 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2024-02-09 | Sell | 46,137 | 35.50 | 1,638,072 | 2024-02-09 19:47:01 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2024-02-09 | Option Exercise | 46,137 | 2.08 | 95,965 | 2024-02-09 19:47:01 |
| KYMR | Kymera Therapeutics, Inc. | Albers Jeffrey W. | Directior | 2024-01-23 | Sell | 10,000 | 30.05 | 300,470 | 2024-01-23 19:37:29 |
| KYMR | Kymera Therapeutics, Inc. | Albers Jeffrey W. | Directior | 2024-01-23 | Option Exercise | 10,000 | 10.34 | 103,400 | 2024-01-23 19:37:29 |
| KYMR | Kymera Therapeutics, Inc. | Chiniara Ellen | Chief Legal Officer | 2024-01-04 | Sell | 3,295 | 22.58 | 74,416 | 2024-01-05 17:15:06 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2024-01-02 | Option Exercise | 9,000 | 2.08 | 18,720 | 2024-01-02 17:43:37 |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Directior | 2023-11-02 | Buy | 414,105 | 12.80 | 5,301,326 | 2023-11-06 18:07:28 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2023-11-03 | Option Exercise | 20,000 | 2.08 | 41,600 | 2023-11-06 18:00:05 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2023-08-08 | Option Exercise | 12,000 | 2.08 | 24,960 | 2023-08-08 16:30:52 |
| KYMR | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | 2023-06-02 | Option Exercise | 10,000 | 2.08 | 20,800 | 2023-06-02 14:17:04 |
| KYMR | Kymera Therapeutics, Inc. | Caughey Elaine | Chief Business Officer | 2023-03-01 | Sell | 714 | 31.00 | 22,132 | 2023-03-03 16:31:17 |
| KYMR | Kymera Therapeutics, Inc. | Gollob Jared | Chief Medical Officer | 2023-03-01 | Sell | 1,298 | 31.00 | 40,233 | 2023-03-03 16:30:52 |
| KYMR | Kymera Therapeutics, Inc. | Jacobs Bruce N. | Chief Financial Officer | 2023-03-01 | Sell | 1,370 | 31.00 | 42,465 | 2023-03-03 16:30:13 |
| KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Directior | 2023-01-11 | Buy | 41,007 | 30.51 | 1,251,191 | 2023-01-13 17:08:35 |
| KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Directior | 2023-01-11 | Sell | 126,474 | 30.22 | 3,821,739 | 2023-01-13 16:53:09 |
| KYMR | Kymera Therapeutics, Inc. | Atlas Venture Fund X, L.P. | 10% Owner | 2023-01-11 | Sell | 126,474 | 30.22 | 3,821,739 | 2023-01-13 16:50:44 |
| KYMR | Kymera Therapeutics, Inc. | Booth Bruce | Directior | 2022-12-14 | Sell | 382,244 | 31.36 | 11,985,954 | 2022-12-16 17:05:47 |
| KYMR | Kymera Therapeutics, Inc. | Atlas Venture Fund X, L.P. | 10% Owner | 2022-12-14 | Sell | 382,244 | 31.36 | 11,985,954 | 2022-12-16 17:03:42 |
| KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | Chief Executive Officer | 2022-12-08 | Option Exercise | 10,000 | 2.08 | 20,800 | 2022-12-08 18:11:29 |
